Showing results (1-10 of 2,393) with videos related to
Sort By:
Pageof 240
Current Opinion in Cardiology|September 14, 2020
Generalizability of Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial in patients with a history of coronary artery bypass graft surgeryAndrew Kosmopoulos, Subodh Verma, Gus Meglis, et al.Journal of the American College of Cardiology|September 24, 2021
Intracranial Hemorrhage During Dual Antiplatelet Therapy: JACC Review Topic of the WeekAndrew C T Ha, Deepak L Bhatt, James T Rutka, et al.Cell Metabolism|November 3, 2021
EMPEROR-Preserved: A promise fulfilledDeepak L Bhatt, Subodh Verma, Bertram PittCell Metabolism|November 7, 2019
The DAPA-HF Trial: A Momentous Victory in the War against Heart FailureDeepak L Bhatt, Subodh Verma, Eugene BraunwaldCell Metabolism|October 24, 2017
CANTOS Ushers in a New Calculus of Inflammasome Targeting for Vascular Protection-and Maybe MoreSubodh Verma, Lawrence A Leiter, Deepak L BhattCell Metabolism|December 6, 2018
Can We DECLARE a Victory against Cardio-Renal Disease in Diabetes?Kim A Connelly, Deepak L Bhatt, Subodh VermaCell Metabolism|July 12, 2023
Inflammation and cholesterol at the crossroads of vascular riskSubodh Verma, C David Mazer, Kim A ConnellyEuropean Heart Journal|January 2, 2022
The year in cardiovascular medicine 2021: diabetes and metabolic disordersFrancesco Cosentino, Deepak L Bhatt, Nikolaus Marx, et al.Current Opinion in Cardiology|August 11, 2017
The coronary heart teamBobby Yanagawa, John D Puskas, Deepak L Bhatt, et al.Current Diabetes Reports|October 23, 2020
The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk ReductionXiaowen Wang, Subodh Verma, R Preston Mason, et al.Pageof 240